Business Description
Pharmosa Biopharm Inc
ISIN : TW0006875008
Description
Pharmosa Biopharm Inc is a world-class biotechnology company focusing on developing a new drug by exploiting proprietary formulation and manufacturing technology.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 13.22 | |||||
| Equity-to-Asset | 0.92 | |||||
| Debt-to-Equity | 0.06 | |||||
| Debt-to-EBITDA | -0.46 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 24.35 | |||||
| Beneish M-Score | -0.98 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year FCF Growth Rate | 55.3 | |||||
| 3-Year Book Growth Rate | 5.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.8 | |||||
| 9-Day RSI | 41.61 | |||||
| 14-Day RSI | 39.21 | |||||
| 6-1 Month Momentum % | -17 | |||||
| 12-1 Month Momentum % | -34.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 25.2 | |||||
| Quick Ratio | 24.92 | |||||
| Cash Ratio | 24.27 | |||||
| Days Inventory | 260.15 | |||||
| Days Sales Outstanding | 89.24 | |||||
| Days Payable | 20.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -33.9 | |||||
| Shareholder Yield % | -14.39 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 26.57 | |||||
| Operating Margin % | -639.02 | |||||
| Net Margin % | -579.83 | |||||
| FCF Margin % | -901.06 | |||||
| ROE % | -17.62 | |||||
| ROA % | -15.71 | |||||
| ROIC % | -85.84 | |||||
| ROC (Joel Greenblatt) % | -144.22 | |||||
| ROCE % | -16.29 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 304.82 | |||||
| PS Ratio | 138.53 | |||||
| PB Ratio | 3.69 | |||||
| Price-to-Tangible-Book | 3.68 | |||||
| EV-to-EBIT | -19.03 | |||||
| EV-to-EBITDA | -20.95 | |||||
| EV-to-Revenue | 109.24 | |||||
| EV-to-FCF | -12.15 | |||||
| Price-to-Net-Current-Asset-Value | 4.68 | |||||
| Price-to-Net-Cash | 4.88 | |||||
| Earnings Yield (Greenblatt) % | -5.25 | |||||
| FCF Yield % | -6.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharmosa Biopharm Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 50.521 | ||
| EPS (TTM) (NT$) | -2.42 | ||
| Beta | 0 | ||
| Volatility % | 52.45 | ||
| 14-Day RSI | 39.21 | ||
| 14-Day ATR (NT$) | 1.583113 | ||
| 20-Day SMA (NT$) | 55.365 | ||
| 12-1 Month Momentum % | -34.87 | ||
| 52-Week Range (NT$) | 48.25 - 125.5 | ||
| Shares Outstanding (Mil) | 129.09 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharmosa Biopharm Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharmosa Biopharm Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pharmosa Biopharm Inc Frequently Asked Questions
What is Pharmosa Biopharm Inc(ROCO:6875)'s stock price today?
The current price of ROCO:6875 is NT$54.30. The 52 week high of ROCO:6875 is NT$125.50 and 52 week low is NT$48.25.
When is next earnings date of Pharmosa Biopharm Inc(ROCO:6875)?
The next earnings date of Pharmosa Biopharm Inc(ROCO:6875) is .
Does Pharmosa Biopharm Inc(ROCO:6875) pay dividends? If so, how much?
Pharmosa Biopharm Inc(ROCO:6875) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers